A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis
Clinical trial NCT05593666 · COMPLETED
Trial details
- NCT number
- NCT05593666
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-27
- Primary completion
- 2025-04-15
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.